Clinical presentation, response to therapy, and outcome of gastroparesis in children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 55, Issue 2, 2012, Pages 185-190

  Rodriguez, Leonel ^a   Irani, Katayun ^b   Jiang, Hongyu ^a   Goldstein, Allan M ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

delayed gastric emptying; gastroparesis; nausea; prokinetic therapy; vomiting

Indexed keywords

AMITRIPTYLINE; CYPROHEPTADINE; DOMPERIDONE; ERYTHROMYCIN; ESOMEPRAZOLE; LANSOPRAZOLE; METOCLOPRAMIDE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; TEGASEROD;

ABDOMINAL PAIN; AGE DISTRIBUTION; BEHAVIOR CHANGE; CLINICAL FEATURE; DIARRHEA; DIET; DISEASE DURATION; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DIZZINESS; DROWSINESS; DRUG ERUPTION; DYSTONIA; GALACTORRHEA; HEADACHE; HUMAN; IRRITABILITY; JEJUNOSTOMY TUBE; MOTOR DYSFUNCTION; NAUSEA; PRIORITY JOURNAL; PYLOROPLASTY; REVIEW; SCORING SYSTEM; SIDE EFFECT; STOMACH EMPTYING; STOMACH FUNDOPLICATION; STOMACH PARESIS; STOMACH TUBE; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

ABDOMINAL PAIN; ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GASTROINTESTINAL TRANSIT; GASTROPARESIS; HUMANS; INFANT; MALE; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NAUSEA; RETROSPECTIVE STUDIES; SEX FACTORS; TREATMENT OUTCOME; VIRUS DISEASES; VOMITING;

EID: 84863819183     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318248ed3f     Document Type: Review

References (26)

1. Reid B, DiLorenzo C, Travis L, et al. Diabetic gastroparesis due to postprandial antral hypomotility in childhood. Pediatrics 1992;90:43-6.
2. Sigurdsson L, Flores A, Putnam PE, et al. Postviral gastroparesis: presentation, treatment, and outcome. J Pediatr 1997;131:751-4.
3. Rosen PR, Treves S. The relationship of gastroesophageal reflux and gastric emptying in infants and children: concise communication. J Nucl Med 1984;25:571-4.
4. Montgomery M, Escobar-Billing R, Hellstrom PM, et al. Impaired gastric emptying in children with repaired esophageal atresia: a controlled study. J Pediatr Surg 1998;33:476-80.
5. Sachdeva P, Malhotra N, Pathikonda M, et al. Gastric emptying of solids and liquids for evaluation for gastroparesis. Dig Dis Sci 2011;56:1138-46.
6. Seibert JJ, Byrne WJ, Euler AR. Gastric emptying in children: unusual patterns detected by scintigraphy. AJRAmJ Roentgenol 1983;141:49-51.
7. Signer E. Gastric emptying in newborns and young infants. Measurement of the rate of emptying using indium-113m-microcolloid. Acta Paediatr Scand 1975;64:525-30.
8. Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology 2011;140:101-15.
9. Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis-clinical characteristics and long-term outcomes. Am J Gastroenterol 1997;92:1501-4.
10. Patterson D, Abell T, Rothstein R, et al. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 1999;94:1230-4.
11. Dhir R, Richter JE. Erythromycin in the short-and long-term control of dyspepsia symptoms in patients with gastroparesis. J Clin Gastroenterol 2004;38:237-42.
12. Woodward MN, Spicer RD. Intrapyloric botulinum toxin injection improves gastric emptying. J Pediatr Gastroenterol Nutr 2003; 37:201-2.
13. Islam S, Vick LR, Runnels MJ, et al. Gastric electrical stimulation for children with intractable nausea and gastroparesis. J Pediatr Surg 2008;43:437-42.
14. Hyman P, Schropp K, Sarosiek I, et al. Feasibility and safety of gastric electrical stimulation for a child with intractable visceral pain and gastroparesis. J Pediatr Gastroenterol Nutr 2009;49:635-8.
15. Anaparthy R, Pehlivanov N, Grady J, et al. Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors. Dig Dis Sci 2009;54:1003-10.
16. Arts J, Caenepeel P, Verbeke K, et al. Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. Gut 2005;54:455-60.
17. Sturm A, Holtmann G, Goebell H, et al. Prokinetics in patients with gastroparesis: a systematic analysis. Digestion 1999;60:422-7.
18. Talley NJ. Diabetic gastropathy and prokinetics. Am J Gastroenterol 2003;98:264-71.
19. Schade RR, Dugas MC, Lhotsky DM, et al. Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis. Dig Dis Sci 1985;30:10-5.
20. Lyday WD 2nd, DiBaise JK. Metoclopramide-stimulated gastric emptying scintigraphy: does it predict symptom response to prokinetic therapy in chronic gastroparesis? Am J Gastroenterol 2002;97:2474-6.
21. Horowitz M, Harding PE, Chatterton BE, et al. Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 1985;30:1-9.
22. Koch KL, Stern RM, Stewart WR, et al. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment. Am J Gastroenterol 1989;84:1069-75.
23. Soykan I, Sarosiek I, McCallum RW. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol 1997;92:976-80.
24. Franzese A, Borrelli O, Corrado G, et al. Domperidone is more effective than cisapride in children with diabetic gastroparesis. Aliment Pharmacol Ther 2002;16:951-7.
25. Richards RD, Davenport K, McCallum RW. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 1993;88:203-7.
26. Erbas T, Varoglu E, Erbas B, et al. Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis. Diabetes Care 1993;16:1511-4.